BRPI0816130A2 - METHODS FOR MAKING A PREPARATION AND INCREASING RESISTANCE TO A VIRAL INFECTION IN AN INDIVIDUAL. - Google Patents

METHODS FOR MAKING A PREPARATION AND INCREASING RESISTANCE TO A VIRAL INFECTION IN AN INDIVIDUAL.

Info

Publication number: BRPI0816130A2
Authority: BR; Brazil
Prior art keywords: individual; preparation; making; methods; viral infection
Prior art date: 2007-08-28

Application number

BRPI0816130-5A2A

Other languages

Portuguese (pt)

Inventor

Otfried Kistner

Christa Tauer

Noel Barrett

Wolfgang Mundt

Original Assignee

Baxter Int

Baxter Healthcare Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-28

Filing date

2008-08-28

Publication date

2015-02-24

2008-08-28 Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int

2015-02-24 Publication of BRPI0816130A2 publication Critical patent/BRPI0816130A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C07K16/1145—
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16261—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Mycology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0816130-5A2A 2007-08-28 2008-08-28 METHODS FOR MAKING A PREPARATION AND INCREASING RESISTANCE TO A VIRAL INFECTION IN AN INDIVIDUAL. BRPI0816130A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US96672407P	2007-08-28	2007-08-28
PCT/US2008/074559 WO2009029695A1 (en)	2007-08-28	2008-08-28	Method for producing viral vaccines

Publications (1)

Publication Number	Publication Date
BRPI0816130A2 true BRPI0816130A2 (en)	2015-02-24

Family

ID=39947984

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816130-5A2A BRPI0816130A2 (en)	2007-08-28	2008-08-28	METHODS FOR MAKING A PREPARATION AND INCREASING RESISTANCE TO A VIRAL INFECTION IN AN INDIVIDUAL.

Country Status (16)

Country	Link
US (2)	US8497112B2 (en)
EP (1)	EP2192917B1 (en)
JP (1)	JP5535910B2 (en)
KR (1)	KR101760844B1 (en)
CN (1)	CN101790381B (en)
AU (1)	AU2008293513B2 (en)
BR (1)	BRPI0816130A2 (en)
CA (1)	CA2696090C (en)
ES (1)	ES2459166T3 (en)
HR (1)	HRP20140375T1 (en)
IL (1)	IL203869A (en)
PL (1)	PL2192917T3 (en)
RU (1)	RU2496519C2 (en)
SG (1)	SG10201404101RA (en)
SI (1)	SI2192917T1 (en)
WO (1)	WO2009029695A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11707520B2 (en)	2005-11-03	2023-07-25	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
DE06808434T1 (en) *	2005-11-04	2009-12-17	Novartis Vaccines And Diagnostics S.R.L.	EMULSIONS WITH FREE AQUEOUS PHASES TENSID AS ADJUVANS FOR SPLIT FLUIDS
NZ582595A (en) *	2007-06-27	2012-07-27	Novartis Ag	Low-additive influenza vaccines
CN105727281A (en)	2009-02-10	2016-07-06	诺华股份有限公司	Influenza vaccines with reduced amounts of squalene
EP2451950B9 (en)	2009-07-06	2016-11-23	Variation Biotechnologies Inc.	Methods for preparing vesicles and formulations produced therefrom
WO2011005772A1 (en)	2009-07-06	2011-01-13	Variation Biotechnologies, Inc.	Methods for preparing vesicles and formulations produced therefrom
GB0918830D0 (en) *	2009-10-27	2009-12-09	Glaxosmithkline Biolog Niederl	Process
CN102858961A (en)	2010-05-03	2013-01-02	葛兰素史密丝克莱恩生物有限公司	Novel method
CA2840079C (en)	2010-07-06	2018-07-03	Variation Biotechnologies Inc.	Compositions and methods for treating influenza
AU2012205315B2 (en)	2011-01-13	2017-05-04	Variation Biotechnologies, Inc.	Methods for preparing vesicles and formulations produced therefrom
CN103501811B (en)	2011-01-13	2016-03-30	变异生物技术公司	Be used for the treatment of compositions and the method for viral infection
AU2012286098C1 (en) *	2011-07-20	2016-09-15	Bgp Products B.V.	Process for producing viral antigen and vaccines
PT2737060T (en) *	2011-07-27	2019-06-05	Flash Therapeutics	Method for the production of retroviral particles useful for transducing eukaryotic cells
WO2013072768A2 (en)	2011-11-18	2013-05-23	Variation Biotechnologies, Inc.	Synthetic derivatives of mpl and uses thereof
CA2894442C (en)	2012-01-12	2020-01-21	Variation Biotechnologies Inc.	Compositions and methods for treating viral infections
EP4008354A1 (en)	2012-01-27	2022-06-08	Variation Biotechnologies Inc.	Methods and compositions for therapeutic agents
US10125402B2 (en) *	2013-10-22	2018-11-13	Roche Molecular Systems, Inc.	Method for measuring cell-free virus particles from dried blood spots
FR3025107B1 (en) *	2014-08-29	2018-10-05	Calixar	PROCESS FOR PREPARING A VACCINAL ANTIGEN, VACCINAL ANTIGEN OBTAINED AND USES
CA3080656A1 (en)	2017-10-30	2019-05-09	Baxalta GmbH	Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111979120B (en) *	2019-05-23	2022-09-27	比欧联科供应链管理(北京)有限公司	Rabies vaccine nucleic acid digestion removal device and experiment method
RU2754398C1 (en) *	2020-06-25	2021-09-01	Общество с ограниченной ответственностью «ФОРТ»	Method for obtaining a tetravalent vaccine for the prevention of influenza

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH589453A5 (en) *	1974-01-14	1977-07-15	Sandoz Ag
FR2475572A1 (en) *	1980-02-11	1981-08-14	Pasteur Institut	PROCESS FOR OBTAINING LIPID ENVELOPE VIRUS FRAGMENTS, PARTICULARLY ANTIGENS USED AS VACCINES, PRODUCTS OBTAINED AND APPLICATIONS
FR2533548B1 (en) *	1982-09-28	1985-07-26	Degremont	METHOD AND APPARATUS FOR ANAEROBIC TREATMENT OF WASTE WATER IN A GRANULAR MATERIAL FILLED FILTER
EP0172433A3 (en) *	1984-08-02	1989-04-05	Tektronix, Inc.	Display method and apparatus employing cursor panning
GB9110808D0 (en) *	1991-05-17	1991-07-10	Retroscreen Ltd	Aids vaccine and method for its production
RU2082433C1 (en) *	1992-07-13	1997-06-27	Николай Владимирович Костючек	Method of influenza vaccine prophylaxis
FR2723740B1 (en) *	1994-08-16	1996-11-08	Pasteur Merieux Serums Vacc	PROCESS FOR THE PREPARATION OF INFLUENZA VIRUS ANTIGENS, ANTIGENS OBTAINED AND THEIR APPLICATIONS
CN1223589A (en) *	1996-05-06	1999-07-21	美国拜尔公司	Cat vaccine containing chlamydia psittaci and preparation method thereof
AT405939B (en) *	1997-02-24	1999-12-27	Immuno Ag	METHOD FOR INACTIVATING LIPID-ENVIRONED VIRUSES
EP1057889B1 (en) *	1998-10-05	2009-04-22	The Research Foundation for Microbial Diseases of Osaka University	Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same
NZ512980A (en) *	1998-12-17	2003-07-25	Aventis Pasteur	Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation
US7521220B2 (en) *	1999-11-26	2009-04-21	Crucell Holland B.V.	Production of vaccines
AR035651A1 (en)	2000-07-28	2004-06-23	Univ Madrid Complutense	USE OF INDOL DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO REDUCE INTRAOCULAR PRESSURE AND A COMPOSITION
GB0024089D0 (en) *	2000-10-02	2000-11-15	Smithkline Beecham Biolog	Novel compounds
TWI228420B (en) *	2001-05-30	2005-03-01	Smithkline Beecham Pharma Gmbh	Novel vaccine composition
RU2195959C1 (en) *	2001-11-02	2003-01-10	Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных	Inactivated vaccine against hens' hydropericarditis syndrome
RU2261111C1 (en) *	2004-04-08	2005-09-27	Сергеев Виталий Александрович	Inactivated vaccine against viral pneumogastroenteritis in cattle and calves and method for prophylaxis of viral pneumogastroenteritis
US8703467B2 (en) *	2004-05-27	2014-04-22	Baxter International Inc.	Inactivation of a pathogen in a sample by a treatment with formalin and UV light
CN1647822A (en) *	2005-02-06	2005-08-03	北京生物制品研究所	Poliomyelitis inactivated vaccine and its preparing method
EP1724338A1 (en) *	2005-05-19	2006-11-22	Crucell Holland B.V.	Methods for the production of a whole-inactivated West Nile Virus vaccine

2008
- 2008-08-28 WO PCT/US2008/074559 patent/WO2009029695A1/en not_active Ceased
- 2008-08-28 HR HRP20140375AT patent/HRP20140375T1/en unknown
- 2008-08-28 SG SG10201404101RA patent/SG10201404101RA/en unknown
- 2008-08-28 CN CN200880105185.5A patent/CN101790381B/en active Active
- 2008-08-28 KR KR1020107006633A patent/KR101760844B1/en active Active
- 2008-08-28 RU RU2010111747/10A patent/RU2496519C2/en not_active IP Right Cessation
- 2008-08-28 BR BRPI0816130-5A2A patent/BRPI0816130A2/en not_active IP Right Cessation
- 2008-08-28 PL PL08828326T patent/PL2192917T3/en unknown
- 2008-08-28 SI SI200831190T patent/SI2192917T1/en unknown
- 2008-08-28 JP JP2010523124A patent/JP5535910B2/en active Active
- 2008-08-28 US US12/199,977 patent/US8497112B2/en active Active
- 2008-08-28 EP EP08828326.2A patent/EP2192917B1/en active Active
- 2008-08-28 ES ES08828326.2T patent/ES2459166T3/en active Active
- 2008-08-28 CA CA2696090A patent/CA2696090C/en active Active
- 2008-08-28 AU AU2008293513A patent/AU2008293513B2/en active Active
2010
- 2010-02-10 IL IL203869A patent/IL203869A/en active IP Right Grant
2013
- 2013-06-26 US US13/928,094 patent/US20130287811A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL2192917T3 (en)	2014-06-30
KR101760844B1 (en)	2017-07-24
AU2008293513A1 (en)	2009-03-05
HRP20140375T1 (en)	2014-06-20
EP2192917A1 (en)	2010-06-09
CA2696090A1 (en)	2009-03-05
SI2192917T1 (en)	2014-05-30
KR20100075865A (en)	2010-07-05
EP2192917B1 (en)	2014-01-29
RU2010111747A (en)	2011-10-10
CA2696090C (en)	2017-06-13
CN101790381B (en)	2014-08-27
US20090060950A1 (en)	2009-03-05
AU2008293513B2 (en)	2013-11-21
IL203869A (en)	2016-05-31
SG10201404101RA (en)	2014-09-26
US20130287811A1 (en)	2013-10-31
JP2010537641A (en)	2010-12-09
CN101790381A (en)	2010-07-28
JP5535910B2 (en)	2014-07-02
ES2459166T3 (en)	2014-05-08
WO2009029695A1 (en)	2009-03-05
HK1143328A1 (en)	2010-12-31
RU2496519C2 (en)	2013-10-27
US8497112B2 (en)	2013-07-30

Publication	Publication Date	Title
BRPI0816130A2 (en)	2015-02-24	METHODS FOR MAKING A PREPARATION AND INCREASING RESISTANCE TO A VIRAL INFECTION IN AN INDIVIDUAL.
ZA201107675B (en)	2012-06-27	Multiple virus resistance in plants
DK2106215T3 (en)	2020-09-28	BREAD WITH INCREASED ARABINOXYLO OLIGOSACCHARID CONTENT
BRPI0807908A2 (en)	2014-06-17	IMPROVEMENTS IN MEDICAL COMPOSITIONS.
BRPI0807453A2 (en)	2014-05-20	SOLID PREPARATION
BRPI0909770A2 (en)	2015-08-11	Vaccine and kit
SI2126093T1 (en)	2013-01-31	Improving protein preparation
DK2138716T4 (en)	2024-03-11	Wing insert
BRPI0807896A2 (en)	2014-06-17	Non-stick BIPOLAR FORCEPS.
BRPI0820307A2 (en)	2019-09-24	human immunodeficiency virus replication inhibitors
FI20080523A0 (en)	2008-09-17	inserter
BRPI0915524A2 (en)	2016-01-26	airfoil set
FI20086250A0 (en)	2008-12-30	Mushroom dogglucans, their preparation and use
DK2125048T3 (en)	2014-10-13	Preparation
IL224147A (en)	2015-07-30	Squash leaf curl virus (slcv) resistance in cucurbits
BRPI0819642A2 (en)	2015-05-26	Method for forming a denture for a patient in a single visit, and, denture
EP2219752A4 (en)	2011-12-21	BOOMERANG
PL2222320T3 (en)	2014-02-28	New milk thistle extract, preparation and application
IT1391276B1 (en)	2011-12-01	PERFECTED HELMET
DK2132234T3 (en)	2013-08-26	Accelerator
NO2022038I1 (en)	2022-09-02	ropeginterferon alfa-2b
BRPI0920833A2 (en)	2015-12-22	benzonorborbenes preparation
BRPI0815595A2 (en)	2015-03-03	ANTI-FUNGAL COMPOSITION
BRPI1015351A2 (en)	2018-05-22	resistance to bacterial infection
BRPI0918169A2 (en)	2015-12-01	interlining with spacer cells

Legal Events

Date	Code	Title	Description
2017-03-28	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-06-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-10-23	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2477 DE 26-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.